Background: Interspinous distraction devices (IPDD) are indicated as stand-alone devices for the treatment of spinal stenosis. The purpose of this study is to evaluate the results of patients undergoing surgery for spinal stenosis with a combination of unilateral microdecompression and interspinous distraction device insertion. Methods: This is a prospective clinical and radiological study of minimum 2 years follow-up. Twenty-two patients (average age 64.5 years) with low-back pain and unilateral sciatica underwent decompressive surgery for lumbar spinal stenosis. Visual Analogue Scale, Oswestry Disability Index and walking capacity plus radiologic measurements of posterior disc height of the involved level and lumbar lordosis Cobb angle were documented both preoperatively and postoperatively. One-sided posterior subarticular and foraminal decompression was conducted followed by dynamic stabilization of the diseased level with an IPDD (X-STOP).
Background
Lumbar spinal stenosis, refractory to nonoperative treatment, has been traditionally treated with surgical decompression achieving good and excellent results in almost 80% of the cases [1] . In case of coexisting instability or deformity or discogenic pain, fusion is added. However, the immobilization of a spinal unit causes significant functional changes to the patients in terms of spinal mobility and symptomatology originating from adjacent segments [2] .
"Dynamic stabilization" spinal system is defined as the system that alters favorably the biomechanics (movement and load transmission) of a spinal motion segment, without immobilization of the segment [3, 4] . X-STOP is an interspinous distraction device (IPDD) leading to indirect decompression by distraction [5] and disc unloading [6] . It is indicated for patients older than 50 years old with symptomatology of neurogenic claudication and radiographic spinal stenosis up to two levels. It has been suggested to be superior to laminectomy with or without fusion for the above indications offering minimal surgical trauma, avoidance of bone removal, immediate symptom relief, fast recovery and rehabilitation and low complication rate [7] [8] [9] . This is the first usage of X-STOP (by St. Francis Medical Technologies, Inc. Alameda, CA and, lately, by Medtronic Inc., Minneapolis, MN) device, an FDA approved IPDD for patients with spinal stenosis [10] , in conjunction with minimally invasive lateral decompression [11] . The purpose of this study is to present the two-year follow-up results of surgical treatment for patients with symptomatology of low-back pain and unilateral sciatica due to spinal stenosis who did not respond to nonoperative treatment. Our hypothesis is that the combination of mini-open lateral decompression and X-STOP insertion causes clinical improvement of symptomatology without lordosis deterioration. Since no control group was used, this mode of treatment is compared to outcomes reported in studies using X-STOP alone for lumbar spinal stenosis.
Methods
This a prospective study of 22 patients aged between 57-71 years (average 64.5 years) with unilateral sciatica and low-back pain, in the form of neurogenic intermittent claudication, who were treated by unilateral microdecompression and X-STOP insertion in our hospital between 2006-2007. All patients consented to participate in the study and ethics committee approval (no 11/2005 424 General Army Hospital, Thessaloniki, Greece) for the study was obtained. The average T-score of bone density measurement (DEXA) studies of the aforementioned patients was −1.9. Patients' activities involved mainly household duties, gardening and daily walking but the disease significantly affected their quality of life. All patients had plain x-rays in standing position, dynamic radiographs in flexion extension and MRI of the lumbar spine. No patient had osteoporosis (T-score>−2.5), more than grade I spondylolisthesis, dynamic instability, motor deficit or severe lumbar spinal stenosis (with or without kissing spinous processes) as these were exclusion criteria in our study and containdications for X-STOP insertion. All patients had both central and lateral spinal stenosis (subarticular, foraminal or both) with disc degeneration at the involved levels.
The degree of spinal stenosis, according to radiologist reading of the MRI, was mild to moderate. For central stenosis, dural sac cross sectional area had to be between 100 and 130mm2 in the central canal area of transverse MRI. Less than 100mm2 was considered severe stenosis and these cases were excluded [12] . Mild to moderate subarticular stenosis was defined as contact or deviation of nerve root in the transverse cut MRI but cases with root deformation were excluded [13] . Finally, cases with foraminal stenosis were included if the epidural fat was shown to be disappearing only partially in the sagittal plane MRI [14] .
In all cases pathology was found at L4-L5 level except for four patients with stenosis both at L3-L4 and L4-L5 levels. Initially nonoperative treatment for at least 3 months was applied for all patients including nonsteroidal anti-inflammatories, physical therapy, bracing and transforaminal epidural steroid injections/selective nerve root injections. When nonoperative treatment did not alleviate their symptoms, surgical treatment was performed. Microdecompression of the subarticular and foraminal stenosis was based on the responses from selective nerve root injections with anesthetic and steroids.
The Oswestry Disability Index (ODI) and the Visual Analogue Scale (VAS) (for low-back pain and leg pain separately) scores were documented preoperatively, at the third week, six months and first year postoperatively and at the last follow-up. Self-rated walking distance preoperatively and after surgery at last follow up as well as satisfaction regarding overall result of back operation, according to questions of Zurich Questionnaire, were evaluated [15] .
Also, segmental lordosis of the involved levels and lumbar lordosis (upper plate of L1 to upper plate of S1) were measured by the Cobb angle in standing x-rays both preoperatively and at the last follow-up. Finally, radiographic posterior disc height of the involved levels was measured preoperatively and at the last follow-up. Radiographic manual measurements were done twice by the first two authors (AP, PC) and the average was recorded.
Statistical analysis both for the functional and radiographic results was performed with the use SSPS 10.0. The comparison was calculated with Student's paired t-test. Statistical significance was considered when p < 0.05.
Surgical technique
Under general anesthesia and prone position on a radiolucent table with padded support at the level of the iliac crests and sternum, slight flexion of hips and knees was preserved so that the subjects lie in a less lordotic position. After an appropriately small skin incision (approximately 4 centimeters), under fluoroscopic control, and subcutaneous tissue incision, the dissection went through the dorsolumbar fascia approximately 5-10 mm lateral to the midline towards the symptomatic side, preserving the supraspinous ligamentous attachment to the fascia. The multifidus was detached from the symptomatic side of the spinous processes and laminar attachments. Retractors were placed to keep the wound open and were being loosened regularly to avoid damage to the retracted muscles. The ligamentum flavum was detached with a freer elevator and then completely resected. The superior and inferior laminae were only partially resected. Decompression of both exiting and transversing nerve roots at that level were performed under microscope magnification. Partial facetectomies (mainly undercutting the superior facet) and foraminal decompressions were carried out with the aid of angled Kerrisson rongeurs of varying widths and lengths and/or a power drill. The adequacy of decompression was checked with foraminal probes. No removal of the central portion of laminae and no discectomy were performed.
Next, the fascia was split longitudinally also to the other, non-decompression, side of midline and multifidus is detached only next to the interspinous area. It was of paramount importance for the stability of the segment to keep the supraspinous and part of the interspinous ligaments intact [16] . A small and, then, a larger blunt curved dilator were inserted across the interspinous space abutting the posterior border of the facet joints at the most anterior margin of the interspinous space. After the larger dilator was removed, a sizing distraction instrument is inserted. The correct implant size was indicated on the sizing instrument by tightening the supraspinous ligament in distraction. An appropriately sized X-STOP device was inserted between the spinous processes until it was flush with the right side of the spinous processes and as much anteriorly as possible in the interlaminar space. The screw hole for the universal wing on the left side was visualized and the universal wing screw was engaged. The two wings were approximated toward the midline and the left-sided universal wing screw was secured with a torque-limiting hexagonal screwdriver. Anteroposterior and lateral fluoroscopy views were taken to verify the proper position.
After completion of both thorough decompression and X-STOP insertion, the dorsolumbar fascia was sutured over a suction drain.
Results
The follow-up period ranged from 24 to 36 months and averaged 27.4 months. All patients were able to return to their daily activities within six weeks postoperatively. Both ODI and VAS low-back and leg pain scores improved significantly postoperatively (p < 0.001) and this improvement deteriorated slightly (p > 0.05) in the last follow-up (Table 1) . Using a 25-point improvement from baseline Oswestry Disability Index score as a success criterion, 20 out of 22 patients (91%) had successful outcomes.
When the self-assessment evaluation of Zurich Questionnaire was used for the satisfaction from surgery, only two patients responded somewhat satisfied while the rest twenty patients (90.9%) declared very satisfied. In terms of walking distance, none deteriorated, six patients improved one grade and four improved two grades (Figure 1) .
The interspinous implants used were mainly 10mm and 12mm height size and 8mm implant was inserted only in two levels.
Radiographic analysis of standing x-rays of the lumbar spine showed a mean increase of 1.8 mm of the posterior intervertebral disc height of the operated levels and the postoperative height was significantly larger than preoperatively (p < 0.001) (Figure 2 ). Specifically, there was an increase of posterior disc height after implant insertion in 23 out of 26 disc spaces. Also, the mean segmental lordosis was significantly decreased (p < 0.001) postoperatively compared to preoperative respective value. However, the mean lumbar lordosis did not show statistical significant change (p > 0.05) in the postoperative period (Table 1) .
In a pilot study of our first patients, the postoperative MRI showed the expansion of the space available for the sac following the unilateral decompression (Figure 3 ).
There were no major complications in our series. No obvious by plain x-rays spinous process fracture was detected; however there was one asymptomatic case of gradual displacement of the superior to the implant spinous process which suggested a possible fracture. Two patients with radiculitis originating from the level above the decompressed level were treated successfully with anti-inflammatory medication five months postoperatively. In another two cases, the X-STOP device was not inserted anteriorly enough in the interspinous space but this did not cause symptoms.
Discussion
The rationale for this study was to evaluate if the combination of direct unilateral decompression and the indirect decompression with an IPDD device (X-STOP) was effective for the patients with neurogenic claudication due to spinal stenosis and, also, to compare our results with historical controls of other studies using only X-STOP device. This study intends to show the validity of the presented method of direct and indirect decompression of neural elements and not to show the superiority to other established treatment methods (stand-alone decompression, stand-alone X-STOP insertion).
The first IPDD implanted in patients with neurogenic intermittent claudicaton (NIC) due to spinal stenosis was the X-STOP (first FDA approved) [3] . X-STOP insertion with blunt instruments only does not violate the supraspinous/interspinous complex and can be implanted under local anesthesia [17] . X-STOP reduces facet load and prevents narrowing of the canal and foramen [18] [19] [20] . As Cabraja et al. described [5] , insertion of an interspinous device can decrease the facet joint back pain. Similarly, patients in our study showed significant less axial low-back pain postoperatively than preoperativiely. However, the main benefit was the decrease of leg pain in the form of neurogenic caludication.
In cases with lateral spinal stenosis including subarticular and foraminal nerve root impingement, indirect decompression by X-STOP insertion only may not be as beneficial when there is long-term inflammation in the area. It is advantageous that a direct decompression is performed in lateral subarticular and foraminal area in order to free nerve roots from adhesions due to the chronic inflammation tissue. This combination of direct (mini-open) and indirect (by X-STOP insertion) decompression was performed in our patients. In a biomechanical cadaveric study of X-STOP device by Fuchs et al. [21] , unilateral facetectomies did not lead to added instability of the spinal unit with interspinous devices and in contrast to the instability caused by bilateral facetectomies.
The addition of X-STOP device can distract the intervertebral space and preserve the nerve-occupying space without sacrificing the mobility of the motion segment [7] [8] [9] . In Table 2 , there is a list of bibliographic studies with patients with spinal stenosis and neurogenic claudication treated surgically with X-STOP only without direct decompression. The patients of our study achieved similar improvement in functional scores and higher satisfaction (except Kuchta study [22] ) in the second postoperative year compared to patients treated with X-STOP only.
In a randomized controlled, prospective, multicenter trial outcome study, patients suffering from neurogenic intermittent claudication treated with X-STOP were compared to outcomes of similargroup patients treated conservatively [9, 10] . These class I clinical data included patients with mild to moderate spinal stenosis. X-STOP was found significantly more effective compared to conservative treatment after two years follow up. The X-STOP patients group had significant improvement of clinical symptoms and function compared with epidural steroid injections treated patient group. Successful outcome in our unicenter study group, even though in smaller numbers, reached to 91% of the patients.
Lee et al [23] . experience similar satisfaction rates with Zucherman et al [10] ,. but the individuals in his study found only 40% improvement in severity of symptoms.
29% of the patients in Siddiqui et al. study [24] lost beneficial effect of X-STOP implantation after the third month and had to have epidural steroid injection in a year's time after the operation. It was presumed that because of the position of the device, bony indentations occur at the contact area of the spinous process and with time this led to reduction of the initial distraction. Kim et al. reported postoperative fractures of the spinous processes diagnosed by CT in 22% of patients with IPDD insertion but only half of them were symptomatic [25] . All of our patients had well seated implants in the anterior interspinous area, except two who did not need revision.
In our study elective microdecompression surgery was combined with X-STOP insertion. The patients included were suffering from mild to moderate severity central and unilateral lumbar spinal stenosis. Conservative treatment had been followed for at least 6 months with no relieving response. The procedure included partial unilateral laminotomy, subarticular and foraminal (undercutting) decompression with an effort to avoid complete facetectomies. After microdecompression, X-STOP was applied at the diseased levels. All the patients were evaluated before surgery and postoperatively at 3 weeks, 6 months, 1 year and 2 years follow-up. Our outcome tools were VAS, ODI and certain questions on walking capacity and patient satisfaction from Zurich Questionnaire, all of which improved significantly. Posterior disc height of the involved level and Cobb angle were documented pre-and postoperatively. Lumbar lordotic Cobb angle did not change statistically significantly even though segmental lordosis decreased. This means that lordosis increased in the adjacent motion segments to improve sagittal balance. In contrary to other studies, posterior intervertebral disc height at the involved levels increased in average 1.8 mm postoperatively compared to preoperatively in accordance to results from Sobottke et al [26] . No major complication, significant blood loss, or slippage of device was detected.
The anatomic advantage of direct decompression of neural tissues is obviously superior to indirect decompression. The financial cost of adding an IPDD in a microdecompression case may be exchanged by the lasting clinical improvement and the preservation of disc height and lordosis.
Limitation to our study is the absence of a control patient group. A prospective randomized study comparing IPDD insertion only to IPDD insertion plus direct decompression is under way. This study provides level IV evidence and should be considered this way.
Conclusions
Direct lateral microdecompression in addition to indirect decompression by an IPDD (X-STOP) insertion is a clinically effective and radiologically viable treatment option for patients with mild to moderate lumbar spinal stenosis.
